Anti-WDR11 monoclonal antibody

Pre-made anti-WDR11 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to WDR11/WDR11 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2275-Ab-1/ GM-Tg-hg-IP2275-Ab-2Anti-Human WDR11 monoclonal antibodyHuman
GM-Tg-rg-IP2275-Ab-1/ GM-Tg-rg-IP2275-Ab-2Anti-Rat WDR11 monoclonal antibodyRat
GM-Tg-mg-IP2275-Ab-1/ GM-Tg-mg-IP2275-Ab-2Anti-Mouse WDR11 monoclonal antibodyMouse
GM-Tg-cynog-IP2275-Ab-1/ GM-Tg-cynog-IP2275-Ab-2Anti-Cynomolgus/ Rhesus macaque WDR11 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2275-Ab-1/ GM-Tg-felg-IP2275-Ab-2Anti-Feline WDR11 monoclonal antibodyFeline
GM-Tg-cang-IP2275-Ab-1/ GM-Tg-cang-IP2275-Ab-2Anti-Canine WDR11 monoclonal antibodyCanine
GM-Tg-bovg-IP2275-Ab-1/ GM-Tg-bovg-IP2275-Ab-2Anti-Bovine WDR11 monoclonal antibodyBovine
GM-Tg-equg-IP2275-Ab-1/ GM-Tg-equg-IP2275-Ab-2Anti-Equine WDR11 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2275-Ab-1/ GM-Tg-hg-IP2275-Ab-2; GM-Tg-rg-IP2275-Ab-1/ GM-Tg-rg-IP2275-Ab-2;
GM-Tg-mg-IP2275-Ab-1/ GM-Tg-mg-IP2275-Ab-2; GM-Tg-cynog-IP2275-Ab-1/ GM-Tg-cynog-IP2275-Ab-2;
GM-Tg-felg-IP2275-Ab-1/ GM-Tg-felg-IP2275-Ab-2; GM-Tg-cang-IP2275-Ab-1/ GM-Tg-cang-IP2275-Ab-2;
GM-Tg-bovg-IP2275-Ab-1/ GM-Tg-bovg-IP2275-Ab-2; GM-Tg-equg-IP2275-Ab-1/ GM-Tg-equg-IP2275-Ab-2
Products NameAnti-WDR11 monoclonal antibody
Formatmab
Target NameWDR11
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-WDR11 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2275-Ag-1Recombinant multi-species WDR11/ BRWD2/ DR11 protein


    Target information

    Target IDGM-IP2275
    Target NameWDR11
    Gene ID55717,207425,309016,714990,477847,101094957,525169,100065386
    Gene Symbol and Synonyms2900055P10Rik,BRWD2,DR11,HH14,mKIAA1351,SRI1,WDR11,WDR15
    Uniprot AccessionQ9BZH6
    Uniprot Entry NameWDR11_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000120008
    Target ClassificationN/A

    The target: WDR11, gene name: WDR11, also named as BRWD2, DR11, HH14, SRI1, WDR15. This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is located in the chromosome 10q25-26 region, which is frequently deleted in gliomas and tumors of other tissues, and is disrupted by the t(10;19) translocation rearrangement in glioblastoma cells. The gene location suggests that it is a candidate gene for the tumor suppressor locus. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.